Schwegman Lundberg & Woessner will be offering a webinar entitled “Interplay Between FDA Law and Patent Law: Avoiding Indigestion After Belcher v. Hospira” on September 27, 2021 from 12:00 pm to 1:30 pm (CT). Suneel Arora, Timothy Christman, Lea Westman, and John Swart of Schwegman Lundberg & Woessner will discuss the Federal Circuit’s decision in Belcher Pharmaceuticals, LLC v. Hospira, Inc., affirming a finding of unenforceability of a patent for inequitable conduct, inferring intent based in part on inconsistent representations that were made by the patentee to the U.S. Food & Drug Administration versus the U.S. Patent & Trademark Office….
